contraindications for glp 1 medications GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 nausea: How to handle

Counselling and management strategies Management is best framed as treating the symptom syndrome while maintaining the metabolic benefits of therapy when safe

negatively impact metabolic health and risk of chronic conditions

Endocr Connect 2017;6:856-65.ArticlePubMedPMC 30

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medicines primarily used to manage type 2 diabetes mellitus and, more recently, obesity

Berberine has gained significant attention for its potential role in weight management, she explained

GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), as well as dual GIP/GLP-1 receptor agonists like tirzepatide (Zepbound, Mounjaro), are not automatically disqualifying medications